Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy

David J. Schwartz, Brian J. Davis, Richard J. Vetter, Thomas M. Pisansky, Michael G. Herman, Torrence M. Wilson, Wayne N. LaJoie, Ann L Oberg

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: To identify factors associated with radiation exposure (RE) to operating room personnel during transperineal interstitial permanent prostate brachytherapy (TIPPB). Methods and Materials: Between May 1998 and December 2000, 155 patients underwent TIPPB with fluoroscopic and ultrasound guidance. Data for each case included: operating room time (OT), anesthesia time (AT), fluoroscopy time (FT), number and type of seed implanted, total seed activity, and resident participation. Results: Personnel RE per case, FT, OT, and AT decreased as case number increased. Whole body badge dose per case decreased from a mean of 0.15±0.01 mSv (15±1 mrem) in 1998 to 0.074±0.011 mSv (7±1 mrem) in 2000. Average FT per case decreased from a mean of 17:27 min (range, 10:40-28:23) in 1998 to 12:08 min (range, 6:40-31:00) in 2000. Resident participation was associated with increased FT. Mean whole body and ring badge doses for the treating radiation oncologist were 0.0076 mSv/min (0.76 mrem/min) and 0.05 mSv/min (5.26 mrem/min) of FT, respectively. Conclusions: FT was the predominant factor that related to RE during TIPPB. Treating radiation oncologists were exposed to less than 20 mSv per 100 cases, significantly less than other fluoroscopically guided procedures. Nonetheless, appropriate radiation exposure precautions during TIPPB should continue.

Original languageEnglish (US)
Pages (from-to)98-102
Number of pages5
JournalBrachytherapy
Volume2
Issue number2
DOIs
StatePublished - 2003

Fingerprint

Brachytherapy
Operating Rooms
Prostate
Fluoroscopy
Seeds
Anesthesia
Radiation Exposure

Keywords

  • Fluoroscopy
  • Prostate brachytherapy
  • Radiation exposure

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy. / Schwartz, David J.; Davis, Brian J.; Vetter, Richard J.; Pisansky, Thomas M.; Herman, Michael G.; Wilson, Torrence M.; LaJoie, Wayne N.; Oberg, Ann L.

In: Brachytherapy, Vol. 2, No. 2, 2003, p. 98-102.

Research output: Contribution to journalArticle

Schwartz, DJ, Davis, BJ, Vetter, RJ, Pisansky, TM, Herman, MG, Wilson, TM, LaJoie, WN & Oberg, AL 2003, 'Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy', Brachytherapy, vol. 2, no. 2, pp. 98-102. https://doi.org/10.1016/S1538-4721(03)00097-7
Schwartz, David J. ; Davis, Brian J. ; Vetter, Richard J. ; Pisansky, Thomas M. ; Herman, Michael G. ; Wilson, Torrence M. ; LaJoie, Wayne N. ; Oberg, Ann L. / Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy. In: Brachytherapy. 2003 ; Vol. 2, No. 2. pp. 98-102.
@article{2b2340b251a44e768b5ee73517b43ea3,
title = "Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy",
abstract = "Purpose: To identify factors associated with radiation exposure (RE) to operating room personnel during transperineal interstitial permanent prostate brachytherapy (TIPPB). Methods and Materials: Between May 1998 and December 2000, 155 patients underwent TIPPB with fluoroscopic and ultrasound guidance. Data for each case included: operating room time (OT), anesthesia time (AT), fluoroscopy time (FT), number and type of seed implanted, total seed activity, and resident participation. Results: Personnel RE per case, FT, OT, and AT decreased as case number increased. Whole body badge dose per case decreased from a mean of 0.15±0.01 mSv (15±1 mrem) in 1998 to 0.074±0.011 mSv (7±1 mrem) in 2000. Average FT per case decreased from a mean of 17:27 min (range, 10:40-28:23) in 1998 to 12:08 min (range, 6:40-31:00) in 2000. Resident participation was associated with increased FT. Mean whole body and ring badge doses for the treating radiation oncologist were 0.0076 mSv/min (0.76 mrem/min) and 0.05 mSv/min (5.26 mrem/min) of FT, respectively. Conclusions: FT was the predominant factor that related to RE during TIPPB. Treating radiation oncologists were exposed to less than 20 mSv per 100 cases, significantly less than other fluoroscopically guided procedures. Nonetheless, appropriate radiation exposure precautions during TIPPB should continue.",
keywords = "Fluoroscopy, Prostate brachytherapy, Radiation exposure",
author = "Schwartz, {David J.} and Davis, {Brian J.} and Vetter, {Richard J.} and Pisansky, {Thomas M.} and Herman, {Michael G.} and Wilson, {Torrence M.} and LaJoie, {Wayne N.} and Oberg, {Ann L}",
year = "2003",
doi = "10.1016/S1538-4721(03)00097-7",
language = "English (US)",
volume = "2",
pages = "98--102",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy

AU - Schwartz, David J.

AU - Davis, Brian J.

AU - Vetter, Richard J.

AU - Pisansky, Thomas M.

AU - Herman, Michael G.

AU - Wilson, Torrence M.

AU - LaJoie, Wayne N.

AU - Oberg, Ann L

PY - 2003

Y1 - 2003

N2 - Purpose: To identify factors associated with radiation exposure (RE) to operating room personnel during transperineal interstitial permanent prostate brachytherapy (TIPPB). Methods and Materials: Between May 1998 and December 2000, 155 patients underwent TIPPB with fluoroscopic and ultrasound guidance. Data for each case included: operating room time (OT), anesthesia time (AT), fluoroscopy time (FT), number and type of seed implanted, total seed activity, and resident participation. Results: Personnel RE per case, FT, OT, and AT decreased as case number increased. Whole body badge dose per case decreased from a mean of 0.15±0.01 mSv (15±1 mrem) in 1998 to 0.074±0.011 mSv (7±1 mrem) in 2000. Average FT per case decreased from a mean of 17:27 min (range, 10:40-28:23) in 1998 to 12:08 min (range, 6:40-31:00) in 2000. Resident participation was associated with increased FT. Mean whole body and ring badge doses for the treating radiation oncologist were 0.0076 mSv/min (0.76 mrem/min) and 0.05 mSv/min (5.26 mrem/min) of FT, respectively. Conclusions: FT was the predominant factor that related to RE during TIPPB. Treating radiation oncologists were exposed to less than 20 mSv per 100 cases, significantly less than other fluoroscopically guided procedures. Nonetheless, appropriate radiation exposure precautions during TIPPB should continue.

AB - Purpose: To identify factors associated with radiation exposure (RE) to operating room personnel during transperineal interstitial permanent prostate brachytherapy (TIPPB). Methods and Materials: Between May 1998 and December 2000, 155 patients underwent TIPPB with fluoroscopic and ultrasound guidance. Data for each case included: operating room time (OT), anesthesia time (AT), fluoroscopy time (FT), number and type of seed implanted, total seed activity, and resident participation. Results: Personnel RE per case, FT, OT, and AT decreased as case number increased. Whole body badge dose per case decreased from a mean of 0.15±0.01 mSv (15±1 mrem) in 1998 to 0.074±0.011 mSv (7±1 mrem) in 2000. Average FT per case decreased from a mean of 17:27 min (range, 10:40-28:23) in 1998 to 12:08 min (range, 6:40-31:00) in 2000. Resident participation was associated with increased FT. Mean whole body and ring badge doses for the treating radiation oncologist were 0.0076 mSv/min (0.76 mrem/min) and 0.05 mSv/min (5.26 mrem/min) of FT, respectively. Conclusions: FT was the predominant factor that related to RE during TIPPB. Treating radiation oncologists were exposed to less than 20 mSv per 100 cases, significantly less than other fluoroscopically guided procedures. Nonetheless, appropriate radiation exposure precautions during TIPPB should continue.

KW - Fluoroscopy

KW - Prostate brachytherapy

KW - Radiation exposure

UR - http://www.scopus.com/inward/record.url?scp=0043062934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043062934&partnerID=8YFLogxK

U2 - 10.1016/S1538-4721(03)00097-7

DO - 10.1016/S1538-4721(03)00097-7

M3 - Article

C2 - 15062147

AN - SCOPUS:0043062934

VL - 2

SP - 98

EP - 102

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 2

ER -